Ramon L. Varcoe, MBBS, MS, PhD

Conference Insights

Results with the Absorb Balloon-Expandable Bioresorbable Drug-Eluting Stent for BTK Occlusive Lesions: The ABSORB BTK Trial

03/06/2017

Ramon L. Varcoe , MBBS, MS, PhD;

This was a first-in-human study. We began working with this new investigational device approximately four years ago. The study itself was a single-center study and is a prospective cohort that we have been performing for slightly less than...

This was a first-in-human study....

03/06/2017

Cath Lab Digest

Clinical Update

Replicating a 2018 Meta-Analysis With More Data and Greater Power: Mortality and Paclitaxel-Coated Device Use in the Lower Extremities

09/07/2021

Ramon L. Varcoe , MBBS, MS, PhD;

The release of the 2018 meta-analysis1 happened to occur during the VERVE Symposium in Sydney, and this publication, highlighting mortality concerns with paclitaxel use in lower-extremity intervention, was a shock to everyone.

The release of the 2018...

09/07/2021

Cath Lab Digest

AMP 2023

FDA Determination: Data Does Not Support an Excess Mortality Risk for Paclitaxel-Coated Devices

10/24/2023

Ramon L. Varcoe , MBBS, MS, PhD;

In this video recorded at AMP 2023, vascular surgeon Dr. Ramon Varcoe talks about his presentation on the new FDA determination that paclitaxel-coated devices are safe for use.

In this video recorded at AMP...

10/24/2023

Vascular Disease Management

Interview

One-Year Results From the LIFE-BTK Trial and 2-Year Results From the SWING Trial

02/07/2024

Ramon L. Varcoe , MBBS, MS, PhD;

VDM spoke with Ramon L. Varcoe, MBBS, MS, PhD, MMed (ClinEpi), about these 2 trials and what the current results mean for patients with PAD.

VDM spoke with Ramon L. Varcoe,...

02/07/2024

Vascular Disease Management

ISET 2023

A Direct Comparison of Long-Term Survival for Major Contemporary EVAR Devices Using Big Data and Linkage Techniques

01/18/2023

Amanda Wright Harvey ;

Ramon L. Varcoe , MBBS, MS, PhD;

According to Dr. Ramon L. Varcoe at ISET 2023, the aim of his study was to use linked clinical registries and administrative data to investigate the primary endpoint—differences in long-term all-cause mortality between contemporary EVAR...

According to Dr. Ramon L. Varcoe...

01/18/2023

Vascular Disease Management

Meeting Exclusive

Long-term Outcomes for Resorbable DES for BTK Applications and LIFE-BTK Trial Update

01/18/2022

Ramon L. Varcoe , MBBS, MS, PhD;

Debra L. Beck , MSc;

At ISET 2022, Dr. Ramon L. Varcoe presented the 5-year findings for the Absorb device and an update on resorbable drug-eluting scaffolds for BTK applications.

At ISET 2022, Dr. Ramon L....

01/18/2022

Vascular Disease Management

Video

Data Transparency, Personalized Care, and Predictable, Patient Level Results!

10/02/2023

Ramon L. Varcoe , MBBS, MS, PhD;

Eric A. Secemsky , MD, MSc, RPVI, FACC, FAHA, FSCAI;

A conversation between Dr. Ramon Varcoe and Dr. Eric Secemsky highlighting the importance of data transparency.

A conversation between Dr. Ramon...

10/02/2023

Vascular Disease Management

ISET 2023

12-Month Results From the SWING Multicentre Study: A Novel Sirolimus-Coated Balloon for Use Below-the-Knee

01/18/2023

Amanda Wright Harvey ;

Ramon L. Varcoe , MBBS, MS, PhD;

Dr. Ramon Varcoe presented results from SWING, a prospective, multicenter, single-arm, feasibility study that evaluated the safety and performance of the Sundance DCB in 35 patients at 8 test sites in Australia, New Zealand, and Europe.

Dr. Ramon Varcoe presented...

01/18/2023

Vascular Disease Management